Applied DNA Sciences, Inc. (APDN)
NASDAQ: APDN · Real-Time Price · USD
2.880
-0.050 (-1.71%)
At close: Sep 4, 2025, 4:00 PM
2.810
-0.070 (-2.43%)
After-hours: Sep 4, 2025, 5:43 PM EDT
Applied DNA Sciences Market Cap
Applied DNA Sciences has a market cap or net worth of $3.71 million as of September 4, 2025. Its market cap has decreased by -53.99% in one year.
Market Cap
3.71M
Enterprise Value
-676.95K
1-Year Change
-53.99%
Ranking
Category
Stock Price
$2.88
Market Cap Chart
Since February 14, 2005, Applied DNA Sciences's market cap has decreased from $43.53M to $3.71M, a decrease of -91.48%. That is a compound annual growth rate of -11.29%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 3, 2025 | 3.78M | -64.53% |
Dec 31, 2024 | 10.67M | 26.43% |
Dec 29, 2023 | 8.44M | -60.60% |
Dec 30, 2022 | 21.41M | -28.83% |
Dec 31, 2021 | 30.09M | 4.33% |
Dec 31, 2020 | 28.84M | 97.79% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 662.38B |
Johnson & Johnson | 428.68B |
AbbVie | 374.26B |
UnitedHealth Group | 278.84B |
AstraZeneca | 254.65B |
Novo Nordisk | 253.55B |
Novartis AG | 248.54B |
Abbott Laboratories | 230.05B |